학술논문
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer
Document Type
Article
Author
Source
In Annals of Oncology June 2016 27(6):1029-1034
Subject
Language
ISSN
0923-7534